Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, BioBase

Premium
Affymetrix last week launched its Genome-Wide Human SNP Array 6.0, a single microarray that measures more than 1.8 million markers for genetic variation.
 
Affy claims the array will enable researchers to perform more powerful whole-genome association studies by genotyping more markers from more individuals at a lower cost per sample. 
 
According to Affy, the SNP Array 6.0 contains more than 900,000 SNPs and more than 946,000 non-polymorphic probes for the detection of copy number variation. The array is used in conjunction with Affy’s Genotyping Console, a software package designed to streamline whole-genome genetic analysis and quality control.
 
The Genotyping Console enables scientists to graphically display quality metrics across sample sets to identify features of interest in their data. In addition, flexible data filtering, data management and visualization export features make it possible to share data with collaborators and downstream application software, Affy said.
 

 
German bioinformatics company BioBase last week said that two of its software platforms are compatible with Affymetrix’s GeneChip microarrary platform.
 
The company said its ExPlain Analysis System and its Transfac database have received GeneChip-compatible status.
 
ExPlain is an integrated analysis system used for transcription regulation and pathway analysis. Transfac stores data on transcription factors, binding sites, and regulated genes.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.